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The tumor microenvironment is a complex milieu of
tumor and host cells. Host cells can include tumor-reactive
T cells capable of killing tumor cells. However, more fre-
quently tumor and host components interact to generate a
highly immune suppressive environment that frustrates
T cell cytotoxicity and promotes tumor progression
through a variety of immune and non-immune mechan-
isms. Myeloid-derived suppressor cells (MDSC) are a
major host component contributing to the immune sup-
pressive environment. MDSC accumulate in most patients
and experimental mice with cancer. They inhibit both
adaptive and innate immunity through a diverse array of
suppressive mechanisms and therefore are a significant
obstacle for natural immunity and for active cancer immu-
notherapies. Their accumulation and suppressive potency
are driven by pro-inflammatory mediators. In addition to
their inherent immune suppressive function, MDSC
amplify the immune suppressive activity of macrophages
and dendritic cells via cross-talk which results in the
up-regulation of inflammatory mediators. Cross-talk
between MDSC and other myeloid cells is itself enhanced
by inflammation, resulting in an autocrine tumor microen-
vironment that sustains and amplifies immune suppression.
This talk will describe the cell-cell interactions used by
MDSC to inhibit anti-tumor immunity and promote
tumor progression, and the role of inflammation in pro-
moting cross-talk between MDSC and other cells in the
tumor microenvironment.
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